| 000 | 01627 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514195108.0 | ||
| 264 | 0 | _c20040914 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0891-3668 | ||
| 024 | 7 |
_a10.1097/01.inf.0000133165.85909.08 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSáez-Llorens, Xavier | |
| 245 | 0 | 0 |
_aSafety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection. _h[electronic resource] |
| 260 |
_bThe Pediatric infectious disease journal _cAug 2004 |
||
| 300 |
_a707-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPalivizumab |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aRespiratory Syncytial Virus Infections _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMoreno, María T | |
| 700 | 1 | _aRamilo, Octavio | |
| 700 | 1 | _aSánchez, Pablo J | |
| 700 | 1 | _aTop, Franklin H | |
| 700 | 1 | _aConnor, Edward M | |
| 773 | 0 |
_tThe Pediatric infectious disease journal _gvol. 23 _gno. 8 _gp. 707-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.inf.0000133165.85909.08 _zAvailable from publisher's website |
| 999 |
_c14995341 _d14995341 |
||